blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2776578

EP2776578 - ASSAY FOR THE PREDICTION OF THERAPEUTIC EFFECTIVENESS OR POTENCY OF MESENCHYMAL STEM CELLS, AND METHODS OF USING SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.10.2015
Database last updated on 15.06.2024
Most recent event   Tooltip02.10.2015Application deemed to be withdrawnpublished on 04.11.2015  [2015/45]
Applicant(s)For all designated states
Allocure, Inc.
25 Corporate Drive, STE 360
Burlington MA 01803 / US
[2014/38]
Inventor(s)01 / BRENNER, Robert, M.
14 Hitching Post Lane
Weston, MA 02493 / US
02 / MOHAMED, Ali, S.
I8427 Thundercloud Rd.
Boyds, MD 20841 / US
03 / MINNING, Dena
870 N. Miramar Ave.
Suite 227
Indialantic, FL 32903 / US
 [2014/38]
Representative(s)Haley, Stephen
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2014/38]
Application number, filing date12788399.907.11.2012
WO2012US63940
Priority number, dateUS201161557616P09.11.2011         Original published format: US 201161557616 P
[2014/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013070765
Date:16.05.2013
Language:EN
[2013/20]
Type: A1 Application with search report 
No.:EP2776578
Date:17.09.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 16.05.2013 takes the place of the publication of the European patent application.
[2014/38]
Search report(s)International search report - published on:EP16.05.2013
ClassificationIPC:C12Q1/68, C12N5/0775
[2014/38]
CPC:
C12N5/0663 (EP,US); C12Q1/6888 (US); A61K35/28 (EP,US);
C12Q1/6881 (EP,US); A61K2035/124 (EP,US); C12N2502/115 (EP,US);
C12Q2600/156 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/38]
TitleGerman:ASSAY ZUR VORHERSAGE DER THERAPEUTISCHEN WIRKUNG ODER POTENZ MESENCHYMALER STAMMZELLEN SOWIE VERWENDUNGSVERFAHREN DAFÜR[2014/38]
English:ASSAY FOR THE PREDICTION OF THERAPEUTIC EFFECTIVENESS OR POTENCY OF MESENCHYMAL STEM CELLS, AND METHODS OF USING SAME[2014/38]
French:DOSAGE PERMETTANT DE PRÉDIRE L'EFFICACITÉ OU LA PUISSANCE THÉRAPEUTIQUE DES CELLULES SOUCHES MÉSENCHYMATEUSES, ET SES PROCÉDÉS D'UTILISATION[2014/38]
Entry into regional phase19.05.2014National basic fee paid 
19.05.2014Designation fee(s) paid 
19.05.2014Examination fee paid 
Examination procedure19.05.2014Examination requested  [2014/38]
17.12.2014Amendment by applicant (claims and/or description)
02.06.2015Application deemed to be withdrawn, date of legal effect  [2015/45]
26.06.2015Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2015/45]
Fees paidPenalty fee
Additional fee for renewal fee
30.11.201403   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2004044142  (BRIGHAM & WOMENS HOSPITAL [US], et al) [A] 1-103 * the whole document *;
 [XY]  - A. ZARJOU ET AL, "Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1", AJP: RENAL PHYSIOLOGY, (20110101), vol. 300, no. 1, doi:10.1152/ajprenal.00594.2010, ISSN 0363-6127, pages F254 - F262, XP055052148 [X] 1,3-5,21,29,30,67-69,89-95 * abstract * * page 255 * * page 261 * [Y] 2,6-20,22-28,31-66,70-88,96-103

DOI:   http://dx.doi.org/10.1152/ajprenal.00594.2010
 [Y]  - GERBITZ A ET AL, "Influence of Polymorphism within the Heme Oxygenase-I Promoter on Overall Survival and Transplantation-Related Mortality after Allogeneic Stem Cell Transplantation", BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, KLUGE CARDEN JENNINGS PUBLISHING, CHARLOTTESVILLE, VA, US, vol. 14, no. 10, doi:10.1016/J.BBMT.2008.08.002, ISSN 1083-8791, (20081001), pages 1180 - 1189, (20080917), XP025431774 [Y] 2,6-20,22-28,31-66,70-88,96-103 * abstract * * page 1182, column 1, paragraph 2 - column 2, paragraph 2; figure 1; table 2 *

DOI:   http://dx.doi.org/10.1016/j.bbmt.2008.08.002
 [A]  - OLIN D. LIANG ET AL, "Mesenchymal Stromal Cells Expressing Heme Oxygenase-1 Reverse Pulmonary Hypertension", STEM CELLS, (20110101), vol. 29, no. 1, doi:10.1002/stem.548, ISSN 1066-5099, pages 99 - 107, XP055052284 [A] 1-103 * the whole document *

DOI:   http://dx.doi.org/10.1002/stem.548
 [A]  - T. TSUBOKAWA ET AL, "Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia", AJP: HEART AND CIRCULATORY PHYSIOLOGY, (20100501), vol. 298, no. 5, doi:10.1152/ajpheart.01330.2008, ISSN 0363-6135, pages H1320 - H1329, XP055052282 [A] 1-103 * the whole document *

DOI:   http://dx.doi.org/10.1152/ajpheart.01330.2008
 [A]  - ZENG BIN ET AL, "Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium", JOURNAL OF BIOMEDICAL SCIENCE, KLUWER ACADEMIC PUBLISHERS, DO, (20101007), vol. 17, no. 1, doi:10.1186/1423-0127-17-80, ISSN 1423-0127, page 80, XP021071263 [A] 1-103 * the whole document *

DOI:   http://dx.doi.org/10.1186/1423-0127-17-80
 [A]  - TANG Y L ET AL, "Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 Vector", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER, NEW YORK, NY, US, vol. 46, no. 7, ISSN 0735-1097, (20051004), pages 1339 - 1350, (20051004), XP027719420 [A] 1-103 * the whole document *
 [A]  - D. CHABANNES ET AL, "A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells", BLOOD, (20071115), vol. 110, no. 10, doi:10.1182/blood-2007-02-075481, ISSN 0006-4971, pages 3691 - 3694, XP055052299 [A] 1-103 * the whole document *

DOI:   http://dx.doi.org/10.1182/blood-2007-02-075481
by applicantWO2010017216
    - SCHINKOTHE ET AL., STEM CELLS DEV., (2008), vol. 17, pages 199 - 206
    - PORADA ET AL., CURR STEM CELL RES THER., (2006), vol. 1, pages 365 - 9
    - GIORDANO ET AL., J CELL PHYSIOL., (2007), vol. 211, pages 27 - 35
    - HUMPHREYS ET AL., MINERVA UROL NEFROL., (2006), vol. 58, pages 329 - 37
    - T6GET ET AL., AM J PHYSIOL RENAL PHYSIOL., (2007), vol. 292, pages F1626 - 35
    - IMBERTI ET AL., J AM SOC NEPHROL., (2007), vol. 18, pages 2921 - 8
    - BI ET AL., J AM SOC NEPHROL., (2007), vol. 18, pages 2486 - 96
    - LANGE ET AL., CELLULAR THERAPY AND TRANSPLANTATION, (2008), vol. 1, pages 49 - 53
    - FERENBACH ET AL., NEPHRON EXP NEPHROL, (2010), vol. 115, pages E33 - E37
    - SIKORSKI ET AL., AM J. PHYSIOL RENAL PHYSIOL, (2004), vol. 286, pages F425 - 441
    - SIKORSKI ET AL., AM J. PHYSIOL. RENAL PHYSIOL., (2004), vol. 286, pages F424 - F441
    - ZAIJOU ET AL., AM J PHYSIOL RENAL PHYSIOL, (2011), vol. 300, pages F254 - F262
    - EXNER ET AL., FREE RADICAL BIOLOGY & MEDICINE, (2004), vol. 37, no. 8, pages 1097 - 104
    - ZARJOU ET AL., AM J PHYSIOL RENAL PHYSIOL, (2011), vol. 300, pages F254 - F262
    - KUNTER ET AL., J AM SOC NEPHROL, (200706), vol. 18, no. 6, pages 1754 - 64
    - OKUDA ET AL., FEBS LETT., (20071002), vol. 581, no. 24, pages 4754 - 60
    - LIANG ET AL., NATURE GENETICS, (2007), vol. 39, no. 2, pages 178 - 188
    - BUHLER ET AL., MOL CANCER RES., (2005), vol. 3, no. 7, pages 365 - 71
    - ROBERTS ET AL., DNA CELL BIOL., (2002), vol. 21, no. 1, pages 11 - 9
    - HOMBACK-KLONICH ET AL., J MOL MCD (BCRL, (2008), vol. 86, no. 12, pages 1301 - 1314
    - ANKRUM ET AL., TRENDS MOL MED., (2010), vol. 16, no. 5, pages 203 - 09
    - HARE ET AL., J. AM COLL CARDIOL, (2009), pages 2227 - 86
    - CAO ET AL., BIOTECHNOL LETT, (2010), vol. 32, pages 725 - 32
    - TOGEL ET AL., STEM CELLS DEV, (2009), vol. 18, pages 475 - 85
    - ANKRUM ET AL., TRENDS MOL MED, (2010), vol. 16, no. 5, pages 203 - 209
    - KEBRIAEI, BIOL BLOOD MARROW TRANSPLANT., (2009), vol. 15, pages 804 - 11
    - HARE ET AL., J AM COLL CARDIOL, (2009), vol. 54, pages 2227 - 86
    - LEE ET AL., J AM SOC NEPHROL, (2002), vol. 13, pages 2753 - 2761
    - XIE ET AL., J AM SOC NEPHROL, (2006), vol. 17, pages 3336 - 3346
    - LANGE, "Accelerated and safe expansion of human mesenchymal stem cells in animal serum-free medium for transplantation and regenerative medicine", J. CELL. PHYSIOL., (2007), vol. 213, doi:doi:10.1002/jcp.21081, pages 18 - 26, XP002545733

DOI:   http://dx.doi.org/10.1002/jcp.21081
    - ZARJOU ET AL., "Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1", AM JPHYSIOL RENAL PHYSIOL, (2011), vol. 300, doi:doi:10.1152/ajprenal.00594.2010, pages F254 - F262, XP055052148

DOI:   http://dx.doi.org/10.1152/ajprenal.00594.2010
    - FERENBACH ET AL., "Hemeoxygenase-1 and Renal Ischaemia-Reperfusion Injury", NEPHRON EXP NEPHROL, (2010), vol. 115, pages E33 - E37
    - SIKORSKI ET AL., "The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury", AM J PHYSIOL RENAL PHYSIOL, (2004), vol. 286, doi:doi:10.1152/ajprenal.00297.2003, pages F425 - F441, XP009166864

DOI:   http://dx.doi.org/10.1152/ajprenal.00297.2003
    - ANKRUM ET AL., "Mesenchymal stem cell therapy: Two steps forward, one step back", TRENDS MOL MED., (2010), vol. 16, no. 5, pages 203 - 209, XP027048782
    - HARE ET AL., "A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Cells (Prochymal) after Acute Myocardial Infarction", JAM COLL CARDIOL., (2009), vol. 54, pages 2227 - 2286
    - CAO ET AL., "Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats", BIOTECHNOL LETT., (2010), vol. 32, pages 725 - 732, XP019787087
    - TÖGEL ET AL., "Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury", STEM CELLS DEV., (2009), vol. 18, pages 475 - 485
    - KEBRIAE ET AL., "Adult Human Mesenchymal Stem Cells Added to Corticostcroid Therapy for the Treatment of Acute Graft-vcrsus-Host Disease", BIOL BLOOD MARROW TRANSPLANT., (2009), vol. 15, pages 804 - 811
    - EXNER ET AL., "The Role of Heme Oxygenase-1 Promoter Polymorphisms in Human Disease", FREE RADICAL BIOLOGY & MEDICINE, (2004), vol. 37, no. 8, doi:doi:10.1016/j.freeradbiomed.2004.07.008, pages 1097 - 104, XP004580137

DOI:   http://dx.doi.org/10.1016/j.freeradbiomed.2004.07.008
    - LANGE ET AL., "Platelet Lysate for Rapid Expansion of Human Mesenchymal Stromal Cells", CELLULAR THERAPY AND TRANSPLANATION, (2008), vol. 1, pages 49 - 53
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.